Q1 2023 Voyager Therapeutics Inc Earnings Call Transcript
Good morning, and welcome to Voyager Therapeutics First Quarter 2023 Conference Call. (Operator Instructions) Please be advised that this call is being recorded at the company's request. A replay of today's call will be available on the Investors Section of the company's website approximately 2 hours after completion of this call.
I would now like to turn the call over to Peter Pfreundschuh, Chief Financial Officer. Please go ahead.
Thank you, and good morning. Joining me on the call today are Dr. Al Sandrock, CEO; and Dr. Todd Carter, our Chief Scientific Officer. We issued our Q1 2023 financial results press release this morning. The press release and 10-Q are available on our website. We plan to provide a brief summary of key highlights from the quarter and reserve the majority of time for Q&A. In a moment, I will turn the call over to Al.
Before I do this, I want to remind everyone that during this call, Voyager representatives may make forward-looking statements, as noted in
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |